End the policies preventing poor countries from accessing low-cost generic versions of expensive name-brand medications

End the Obama administration has aggressive policies that prevent poor countries from accessing low-cost generic versions of expensive name-brand medications, despite persistent calls from Doctors Without Borders for the White House to reverse course. The administration's policies create public health barriers for poor countries and in favor of international conglomerate pharmaceutical companies profits.